Patent US5665360A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5665360A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of treating peripheral neuropathies of the feet and legs

Assignee: Individual
•
Filing: 1995-09-15
•
Granted: 1997-09-09
•
Expires: 2015-09-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Peripheral neuropathies associated with Diabetes Mellitus and infection with the AIDS virus may be treated effectively by the periodic topical application of a composition containing capsicum oleoresin as the active ingredient. The oleoresin is incorporated into a pharmaceutically acceptable carrier to form a lotion, ointment, cream or the like. When applied to the skin of the affected area at least daily, pain and burning associated with the neuropathy become reduced in severity or eliminated.

Inventors

  • 👤 Richard H. Mann

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 23:09
CPC Classifications
A; A61; A61K; A61K36/00; A61K36/18; A61K36/185; A61K36/81

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 77 words
A method of treating pain or burning sensations of peripheral neuropathies of the feet and legs due to infection with the acquired immune deficiency syndrome virus or associated with acquired immune deficiency syndrome treatments, the method comprising topically applying an effective amount of a capsicum oleoresin composition in a pharmaceutically acceptable carrier to the affected areas of the feet and legs for a time sufficient to relieve the symptoms due thereto, said composition comprising crude capsicum oleoresin.
Claim 2
Independent Claim 77 words
A method of treating pain or burning sensations of peripheral neuropathies of the feet and legs due to infection with the acquired immune deficiency syndrome virus or associated with acquired immune deficiency syndrome treatments, the method comprising topically applying an effective amount of a capsicum oleoresin composition in a pharmaceutically acceptable carrier to the affected areas of the feet and legs for a time sufficient to relieve the symptoms due thereto, said composition comprising crude capsicum oleoresin.
Claim 3
Dependent Claim 13 words
The method of claim 1, wherein the composition is applied at least daily.
Claim 4
Dependent Claim 15 words
The method of claim 1, in which the composition is applied more than once daily.
Claim 5
Dependent Claim 23 words
The method of claim 1, wherein the oleoresin is present in an amount of not less than about 0.25% by weight of carrier.
Claim 6
Dependent Claim 23 words
The method of claim 1, wherein the oleoresin is present in the range from about 0.25% to about 50% by weight of carrier.
Claim 7
Independent Claim 63 words
A method of treating pain or burning sensations of peripheral neuropathies of the feet and legs due to Diabetes Mellitus, the method comprising topically applying to the affected areas of the feet and legs an effective amount of a capsicum oleoresin composition in a pharmaceutically acceptable carrier for a time sufficient to relieve the symptoms due thereto, said composition comprising crude capsicum oleoresin.
Claim 8
Independent Claim 63 words
A method of treating pain or burning sensations of peripheral neuropathies of the feet and legs due to Diabetes Mellitus, the method comprising topically applying to the affected areas of the feet and legs an effective amount of a capsicum oleoresin composition in a pharmaceutically acceptable carrier for a time sufficient to relieve the symptoms due thereto, said composition comprising crude capsicum oleoresin.
Claim 9
Dependent Claim 13 words
The method of claim 6, wherein the composition is applied at least daily.
Claim 10
Dependent Claim 15 words
The method of claim 6, in which the composition is applied more than once daily.
Claim 11
Dependent Claim 23 words
The method of claim 6, wherein the oleoresin is present in an amount of not less than about 0.25% by weight of carrier.
Claim 12
Dependent Claim 23 words
The method of claim 6, wherein the oleoresin is present in the range from about 0.25% to about 50% by weight of carrier.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-09-08 2001-03-10 2001-09-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-09-08 2005-03-10 2005-09-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-09-08 2009-03-10 2009-09-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag